Brazil reviews emergency use request for vaccine made by China's CanSino

BRASILIA - Brazil's health regulator Anvisa said on Wednesday it was reviewing a request for the emergency use of the COVID-19 single-shot vaccine developed by Chinese laboratory CanSino Biologics.

Anvisa said it received the request late on Tuesday from Belcher Farmaceutica, the Brazilian representative of CanSino, and it would take up to seven days to make a decision, if the papers are in order. "The Cansino vaccine, effective with just one dose, is being used in China. China is committed to continue and expand its vaccine partnership with Brazil," China's ambassador to Brazil, Yang Wanming, tweeted on Wednesday.